4D Pharma PLC Warrant
LBPSW
LBPSW was delisted on the 29th of June, 2022.
0 hedge funds and large institutions have $0 invested in 4D Pharma PLC Warrant in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.
100% less funds holding
Funds holding: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $6K → $0 (-$6K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$2K |
| 2 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$2K |
| 3 |
HF
HRT Financial
New York
|
-$1K |
| 4 |
Walleye Capital
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AA
1
AQR Arbitrage
Greenwich,
Connecticut
| – | -$2K | -55,653 | Closed |
|
|
YCM
2
Yakira Capital Management
Westport,
Connecticut
| – | -$2K | -42,326 | Closed |
|
|
HF
3
HRT Financial
New York
| – | -$1K | -40,178 | Closed |
|
|
4
Walleye Capital
New York
| – | -$1K | -16,000 | Closed |
|
LBPSW Hedge Fund Activity: Q3 2022 in Review
0 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in 4D Pharma PLC Warrant (LBPSW) for Q3 2022, worth a combined $0 — down 100% from $6K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of LBPSW and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was AQR Arbitrage, exiting entirely with an estimated $2K sold.
- 0 institutional investors held 4D Pharma PLC Warrant (LBPSW) as of Q3 2022, down from 4 in Q2 2022.
- Funds reported $0 of 4D Pharma PLC Warrant stock for Q3 2022, down 100% quarter-over-quarter.
- 0 funds opened new 4D Pharma PLC Warrant positions in Q3 2022 and 4 closed out, a net change of -4 holders.
- The largest 4D Pharma PLC Warrant seller in Q3 2022 was AQR Arbitrage, an estimated $2K sold.
Based on aggregated 13F filings for Q3 2022.